This study for a new treatment hopes to help those affected by reducing the risk of experiencing a heart attack, a stroke, or a kidney event such as kidney failure.
If you have a BMI of 27 or higher, have previously experienced an event like a heart attack or stroke and are more at risk of experiencing further events, this study could be of interest to you.
If you:
Have experienced a heart attack or stroke
Have chronic kidney disease
Have a high BMI (27 or over)
This study could be of interest and benefit to you.
Participation in the study will involve taking the study treatment once a week for the duration of the study and will also involve regular visits to our clinics in either Birmingham or Liverpool.
You will receive compensation for your study related time and travel.
Participation in clinical trials provides access to innovative and potentially life-saving treatments. It also contributes to medical research, benefiting both current and future healthcare outcomes. It provides cutting-edge medical care under professional supervision and empowers individuals to contribute to the well-being of society. However, participants should carefully weigh up the risks and benefits and seek advice from their doctor before taking part in a trial.
The conduct of clinical trials is subject to strict regulations and ethical guidelines. All of our trials are submitted to and approved by a research ethics committee in the UK. The safety of the participants is paramount at all times. While all medical interventions involve a degree of risk, safety measures are taken in the design of each study to minimise potential risks. Participants are informed of potential risks before agreeing to participate, and trials are closely monitored by medical professionals and regulatory authorities to ensure safety throughout the process. If at any point you wish to withdraw from the trial, you can, of course, do so.
.jpg)
